FIM
NTLA icon

Farmhouse Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Farmhouse Investment Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1.97M Buy
68,800
+26,800
+64% +$780K 1.05% 16
2018
Q2 		$1.15M Hold
42,000
– – 0.7% 16
2018
Q1 		$886K Buy
+42,000
New +$1.03M 0.6% 16

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Farmhouse Investment Management's NTLA Position: Q3 2018 in Review

Farmhouse Investment Management increased its Intellia Therapeutics (NTLA) stake by 64% in Q3 2018, buying an estimated $780K and bringing the position to 68,800 shares worth $1.97M. The position accounts for 1.05% of the portfolio, ranked #16.

Farmhouse Investment Management first reported a position in NTLA in Q1 2018 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold NTLA as of Q3 2018.

  • Farmhouse Investment Management held 68,800 shares of Intellia Therapeutics worth $1.97M as of Q3 2018.
  • Farmhouse Investment Management bought 26,800 Intellia Therapeutics shares in Q3 2018, an estimated $780K.
  • Intellia Therapeutics made up 1.05% of Farmhouse Investment Management's portfolio in Q3 2018, its #16 holding.
  • Farmhouse Investment Management first reported a position in Intellia Therapeutics in Q1 2018 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2018.

Based on Farmhouse Investment Management's 13F filing for Q3 2018, filed 15 Nov 2018.